Morphology of Interleukin-2-Stimulated Human Peripheral Blood Mononuclear Effector Cells Killing Glioma-Derived Tumor Cells In Vitro
- 5 April 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 80 (3), 171-177
- https://doi.org/10.1093/jnci/80.3.171
Abstract
This is the first morphological study of interleukin-2-stimulated human peripheral blood mononuclear(PBM) cells resulting in lympokine-activated killer(LAK) cell activity against human glioma-derived tumorcells in vitro, in which high-resolution differential interference video light microscopy, scanning electron microscopy, and transmission electron microscopy were used. A subset of cells within the LAK cell population are the effector cells and have an asymmetric cellulararchitecture characteristic of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. Upon binding to target cells, the LAK effector cell nucleus is positioned away from the target cell, whereas the granules, Golgi apparatus, and microtubules orient toward the target cell. These LAK-glioma cell conjugates form very tight plasma membrane bonds with numerous interdigitations, and vesicles were found in the small extracellular spaces between the cells. This morphology was not observed in unstimulated PBM-glioma cell co-cultures. Glioma-derived cells react to LAK effector cells by blebbing, becoming round, and rapidly detaching from the substracte. The injured glioma-derived cells had a highly condensed cytoplasm and chromatin, lobular nucleus, and severe plasma membrane blebs, which are consistent with an apoptotic rather than an osmotic lysis mechanism of cell death. This study provides morphological evidence that supports a common cytotoxic mechanism for CTLs, NK cells, and LAK effector cells. The cytotoxic mechanism is based on the local exocytosis of vesicles by the effector cell into the small extracellular space between the effector-target cell conjugate. Granules found in CTLs, NK cells, and LAK cells contain a pore-forming protein that inserts holes in the target cell's plasma membrane through which a lethal substance(s) not yet identified is thought to enter the cell. [J Natl Cancer Inst 1988;80:171–177]Keywords
This publication has 9 references indexed in Scilit:
- In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.The Journal of Immunology, 1984
- Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization.The Journal of Experimental Medicine, 1984
- Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors.The Journal of Immunology, 1984
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2International Journal of Cancer, 1981
- Permeability changes induced in erthrocyte ghost targets by antibody-dependent cytotoxic effector cells: evidence for membrane pores.The Journal of Immunology, 1980
- ELECTRON-MICROSCOPIC DEMONSTRATION OF LESIONS IN TARGET-CELL MEMBRANES ASSOCIATED WITH ANTIBODY-DEPENDENT CELLULAR CYTO-TOXICITY1980
- MICROCINEMATOGRAPHIC AND ELECTRON-MICROSCOPIC ANALYSIS OF TARGET-CELL LYSIS INDUCED BY CYTOTOXIC LYMPHOCYTES-T1979